1. Within your health trust how many patients have been treated in the past 6 months for head and neck cancer (Squamous cell carcinoma)?
A) 40 patients including cancer of the thyroid
2. Of these patients how many are locally advanced and how many are recurrent and/or metastatic head and neck cancer patients?
· Locally advanced
· Recurrent metastatic
· Unknown
A) 19 – Locally advanced
6 – Recurrent metastatic
3. Within your health trust how many patients have been treated in the past 6 months for head and neck cancer (Squamous cell carcinoma) with the following agents?
· Carboplatin (only or in combination with 5-FU)
· Cisplatin (only or in combination with 5-FU)
· Cetuximab with/without chemotherapy
· Cetuximab with radiotherapy
· Pembrolizumab monotherapy
· Pembrolizumab with chemotherapy
· Nivolumab
· Docetaxel (only or in combination with 5-FU)
· Fluorouracil (5FU)
· Radiotherapy only
· Other
A) Carboplatin (only or in combination with 5-FU) – 0
Cisplatin (only or in combination with 5-FU) – 0
Cetuximab with/without chemotherapy - 0
Cetuximab with radiotherapy - Information not recorded on system
Pembrolizumab monotherapy – 0
Pembrolizumab with chemotherapy – 0
Nivolumab - 0
Docetaxel (only or in combination with 5-FU) – 0
Radiotherapy only – Information not recorded on system
Other – Information not recorded on system
4. Within your health trust how many patients have been treated in the past 6 months with the following agent for colorectal cancer [CRC];
· Aflibercept
· Bevacizumab
· Capecitabine
· CAPIRI
· CAPOX
· Cetuximab not in combination with FOLFIRI or FOLFOX
· Cetuximab in combination with FOLFIRI
· Cetuximab in combination with FOLFOX
· Irinotecan
· FOLFIRI
· FOLFOX
· Oxaliplatin
· Panitumumab not in combination with FOLFIRI or FOLFOX
· Panitumumab in combination with FOLFIRI
· Panitumumab in combination with FOLFOX
· Nivolumab
· Raltitrexed
· Ramucirumab
· Regorafenib
· Sorafenib
· 5FU only
· Tegafur Uracil + 5FU
· Trifluridine–tipiracil
· XELOX
· Other
A) Aflibercept – Less than 5
Bevacizumab – 0
Capecitabine – 41
CAPIRI – Information not recorded
CAPOX – Information not recorded
Cetuximab not in combination with FOLFIRI or FOLFOX – Information not recorded on system
Cetuximab in combination with FOLFIRI – Information not recorded on system
Cetuximab in combination with FOLFOX – Information not recorded on system
Irinotecan - 39
FOLFIRI - Information not recorded on system
FOLFOX - Information not recorded on system
Oxaliplatin - 41
Panitumumab not in combination with FOLFIRI or FOLFOX -0
Panitumumab in combination with FOLFIRI - 0
Panitumumab in combination with FOLFOX -0
Nivolumab - 0
Raltitrexed - Less than 5
Ramucirumab - 0
Regorafenib - 0
Sorafenib - 0
5FU only - Information not recorded on system
Tegafur Uracil + 5FU - 0
Trifluridine–tipiracil - 0
XELOX - Information not recorded on system
Other - Information not recorded on system
Please note that we are unable to provide the data for categories where there are less than 5 individuals involved in the question, as the disclosure of data could lead to an individual being identified or personal data being disclosed in breach of the Data Protection Act.